全文获取类型
收费全文 | 279篇 |
免费 | 39篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 21篇 |
基础医学 | 10篇 |
口腔科学 | 12篇 |
临床医学 | 40篇 |
内科学 | 49篇 |
皮肤病学 | 2篇 |
神经病学 | 12篇 |
特种医学 | 41篇 |
外科学 | 14篇 |
综合类 | 5篇 |
预防医学 | 99篇 |
眼科学 | 4篇 |
药学 | 11篇 |
肿瘤学 | 9篇 |
出版年
2023年 | 2篇 |
2022年 | 5篇 |
2021年 | 6篇 |
2020年 | 5篇 |
2019年 | 2篇 |
2018年 | 8篇 |
2017年 | 18篇 |
2016年 | 9篇 |
2015年 | 8篇 |
2014年 | 10篇 |
2013年 | 25篇 |
2012年 | 6篇 |
2011年 | 10篇 |
2010年 | 12篇 |
2009年 | 13篇 |
2008年 | 5篇 |
2007年 | 11篇 |
2006年 | 9篇 |
2005年 | 6篇 |
2004年 | 8篇 |
2003年 | 3篇 |
2002年 | 3篇 |
2001年 | 8篇 |
1999年 | 7篇 |
1998年 | 8篇 |
1997年 | 12篇 |
1996年 | 11篇 |
1995年 | 12篇 |
1994年 | 15篇 |
1993年 | 6篇 |
1992年 | 6篇 |
1991年 | 2篇 |
1989年 | 7篇 |
1988年 | 6篇 |
1987年 | 6篇 |
1986年 | 4篇 |
1985年 | 2篇 |
1984年 | 6篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1980年 | 2篇 |
1975年 | 1篇 |
1969年 | 2篇 |
1968年 | 1篇 |
1965年 | 1篇 |
1963年 | 1篇 |
1957年 | 1篇 |
1943年 | 2篇 |
1939年 | 1篇 |
1937年 | 1篇 |
排序方式: 共有330条查询结果,搜索用时 7 毫秒
91.
92.
Adalgiza M Moreno Renata RT Castro Pedro PS Sorares Mauricio Sant' Anna Sergio LD Cravo Antônio CL Nóbrega 《Journal of cardiothoracic surgery》2011,6(1):62
Background
The treatment of coronary artery disease (CAD) seeks to reduce or prevent its complications and decrease morbidity and mortality. For certain subgroups of patients, coronary artery bypass graft surgery (CABG) may accomplish these goals. The objective of this study was to assess the pulmonary function in the CABG postoperative period of patients treated with a physiotherapy protocol. 相似文献93.
94.
Use of I-131 labeled, murine Fab against a high molecular weight antigen of human melanoma: preliminary experience 总被引:1,自引:0,他引:1
Larson SM; Carrasquillo JA; McGuffin RW; Krohn KA; Ferens JM; Hill LD; Beaumier PL; Reynolds JC; Hellstrom KE; Hellstrom I 《Radiology》1985,155(2):487-492
High molecular weight antigen (HMWA) is a tumor-associated proteoglycan of human malignant melanoma. I-131 labeled Fab fragments of these specific antibodies were used for preliminary feasibility studies for radioimmunodetection and therapy of human subjects who had inoperable metastatic melanoma. Ten patients received tracer doses of 5-13 mCi (185-481 MBq) of I-131 (anti-HMWA) Fab. All patients (8/8) who had melanoma lesions greater than 1 cm by correlative diagnostic methods had one or more lesions that had localization to tumor of the radiolabeled Fab. In all, 17 of 23 (74%) documented metastases were seen. There were no false positives in this series. Two patients who had avid uptake received potentially radiotherapeutic doses of 142 mCi (5,254 MBq) (one patient) and 181 mCi (6,697 MBq) and 193 (7,141 MBq) (total: 374 mCi or 13,838 MBq) (one patient). For both of these patients, whole body imaging studies showed that the localization of the high dose I-131 Fab was predominantly in tumor. The patient who received the larger dose showed a greater than 50% reduction in the size of pelvic and pericaval nodes, with stabilization of disease at the smaller nodal size for a period of three months. On whole body images, the anti-Fab HMWA appears to be more tumor selective than Fab preparations that target the p97 antigen for melanoma, and there is less uptake in liver. 相似文献
95.
96.
Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico 总被引:9,自引:0,他引:9
García-García ML Ponce de León A Jiménez-Corona ME Jiménez-Corona A Palacios-Martínez M Balandrano-Campos S Ferreyra-Reyes L Juárez-Sandino L Sifuentes-Osornio J Olivera-Díaz H Valdespino-Gómez JL Small PM 《Archives of internal medicine》2000,160(5):630-636
BACKGROUND: Consequences of drug-resistant tuberculosis (TB) in developing countries using directly observed treatment, short-course (DOTS), are not well defined. OBJECTIVE: To determine the impact of drug resistance on clinical outcome and transmission of TB under programmatic conditions. PATIENTS AND METHODS: A prospective cohort and molecular epidemiologic study was conducted in southern Mexico. Between March 1995 and February 1998 all patients with persistent cough whose sputa had acid-fast bacilli (AFB) underwent clinical and mycobacteriologic evaluation (species identification, drug susceptibility testing, and IS6110-based genotyping). Treatment was provided in accordance with Mexico's National Tuberculosis Program. Clinical and microbiologic outcomes and molecular epidemiologically defined transmission were measured. RESULTS: Mycobacterium tuberculosis was isolated from 238 of the 284 AFB smear-positive persons. The overall rate of resistance was 28.4% (new, 20.7%; retreated, 54.7%), and 10.8% (new, 3.3%; retreated, 35.8%) had multi-drug-resistant TB (ie, resistance to isoniazid and rifampin). After treatment, 75% (new, 81.0%; retreated, 52.8%) were cured, 8% (new, 7.8%; retreated, 7.5%) abandoned therapy, 9% (new, 3.9%; retreated, 28.3%) had treatment failure, and 4% (new, 3.3%; retreated, 7.5%) died. Another 2% of patients relapsed, and 9% died during a median of 24.4 months of follow-up. Drug-resistance was a strong independent risk factor for treatment failure. Being infected with multi-drug-resistant TB was the only factor associated with a decreased likelihood of being in a restriction fragment length polymorphism cluster. CONCLUSIONS: Despite the use of DOTS, patients with drug-resistant TB had a dramatically increased probability of treatment failure and death. Although multi-drug-resistant TB may have a decreased propensity to spread and cause disease, it has a profoundly negative impact on TB control. 相似文献
97.
98.
99.
100.